Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme targets, making it valuable in drug discovery. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) for oncology and inflammatory diseases. Also utilized in research settings for building complex heterocyclic systems in medicinal chemistry.